Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profilingBerzsenyi, M.; Roberts, S.; Beard, M.
2015Oyster viperin retains direct antiviral activity and its transcription occurs via a signalling pathway involving a heat-stable haemolymph proteinGreen, T.; Speck, P.; Geng, L.; Raftos, D.; Beard, M.; Helbig, K.
2004Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studiesBeard, M.
2005Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effectorHelbig, K.; Lau, D.; Semendric, L.; Harley, H.; Beard, M.
2015Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.Aloia, A.; Eyre, N.; Black, S.; Bent, S.; Gaeguta, A.; Guo, Z.; Narayana, S.; Chase, R.; Locarnini, S.; Carr, J.; Howe, J.; Beard, M.
2013Bioinformatics methods for the analysis of hepatitis virusesMoriconi, F.; Beard, M.; Yuen, L.
2012HIV-1 infection of human macrophages directly induces viperin which inhibits viral productionNasr, N.; Maddocks, S.; Turville, S.; Harman, A.; Woolger, N.; Helbig, K.; Wilkinson, J.; Bye, C.; Wright, T.; Rambukwelle, D.; Donaghy, H.; Beard, M.; Cunningham, A.
2012The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatmentHelbig, K.; Beard, M.
2012Antiviral resistance and direct-acting antiviral agents for HCVAloia, A.; Locarnini, S.; Beard, M.